Watch KRRO. Know when insiders buy.
One email the day a filing lands. Free.
Work order
36
FLAG · insiders 33, shorts 38
Insiders, 90 days
−$402K
net selling · 0 buys, 3 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $180.2MP/E —DIV YIELD —FCF YIELD -37.87%REV TTM $2.4M −62.1%NET INCOME −$106.6MNET CASH $24.7M52W 5.28 – 51.36SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $0 | −100.0% | — | −$20.1M | −$18.9M | — | -1.07 | −$17M | $37K | −$17M | Aug 6 |
| Q1 2026 · Mar 31 | $0 | −100.0% | — | −$20.4M | −$19.6M | — | -1.69 | −$16.1M | $21K | −$16.1M | Aug 6 |
| Q4 2025 · Dec 31derived | $1.3M | −43.1% | — | −$50.4M | −$50M | — | -5.32 | −$17.7M | $84K | −$17.8M | Mar 12 |
| Q3 2025 · Sep 30 | $1.1M | — | — | −$19.2M | −$18.1M | — | -1.92 | −$17.2M | $175K | −$17.4M | Nov 12 |
| Q2 2025 · Jun 30 | $1.5M | — | — | −$27.2M | −$25.8M | — | -2.74 | −$19.2M | $140K | −$19.4M | Aug 6 |
| Q1 2025 · Mar 31 | $2.5M | — | — | −$25M | −$23.4M | — | -2.49 | −$24.5M | $119K | −$24.6M | Aug 6 |
| Q4 2024 · Dec 31derived | $2.3M | — | — | −$23M | −$21.2M | — | -2.26 | −$7.5M | $1.5M | −$8.9M | Mar 12 |
| Q3 2024 · Sep 30 | $0 | — | — | −$23.3M | −$21M | — | -2.26 | −$16.1M | $4.9M | −$21M | Nov 12 |
| Q2 2024 · Jun 30 | $0 | — | — | −$24.1M | −$21.8M | — | -2.43 | −$14.6M | $6M | −$20.6M | Nov 12 |
| Q1 2024 · Mar 31 | $0 | — | — | −$21.5M | −$19.6M | — | -2.44 | −$21.9M | $5.6M | −$27.5M | Nov 12 |
| Q4 2023 · Dec 31derived | — | — | — | −$26.9M | −$25.4M | — | 147.86 | −$21.1M | $1.7M | −$22.8M | Mar 18 |
| Q3 2023 · Sep 30 | — | — | — | −$19.1M | −$18.5M | — | -65.08 | −$11.8M | $246K | −$12M | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $6.4M | — | −$121.9M | −$117.3M | -1834.5% | -12.48 | −$78.6M | $518K | −$79.1M | — | — |
| FY2024 · to Dec 31 | $2.3M | — | −$91.9M | −$83.6M | -3680.4% | -9.37 | −$60.1M | $17.9M | −$78M | — | — |
| FY2023 · to Dec 31 | $0 | — | −$84.5M | −$81.2M | — | -53.08 | −$67.3M | $7.8M | −$75.1M | — | — |
| FY2022 · to Dec 31 | $0 | — | −$59M | −$58M | — | -227.42 | −$53.6M | $5.1M | −$58.8M | — | — |
| FY2021 · to Dec 31 | $14.1M | — | −$84M | −$84.7M | -602.0% | -2.47 | −$76.1M | $2.9M | −$79M | — | — |
| FY2020 · to Dec 31 | $37M | — | −$27.6M | −$26.5M | -71.7% | -0.82 | −$45.2M | $6.7M | −$51.9M | — | — |
Every number comes from Korro Bio, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.